Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Backman

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|February 17, 2001
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrationsC Kyrklund, J T Backman, K T Kivistö, et al.
Pharmacology & Toxicology|December 23, 1999
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitroJ S Wang, J T Backman, X Wen, et al.
Clinical Pharmacology and Therapeutics|April 5, 2008
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivoA Tornio, M Niemi, M Neuvonen, et al.
Anaesthesia and Intensive Care|April 1, 2016
Intravenous lipid emulsion for levobupivacaine intoxication in acidotic and hypoxaemic pigsJ A Heinonen, M B Skrifvars, J Haasio, et al.
Pharmacology & Toxicology|November 24, 1999
Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazoleJ S Wang, X Wen, J T Backman, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylationJ T Backman, J Mäenpää, D J Belle, et al.
European Journal of Clinical Pharmacology|May 25, 2001
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazoleK T Kivistö, J S Wang, J T Backman, et al.
Clinical Pharmacology and Therapeutics|February 24, 2015
Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humansE K Tarkiainen, M T Holmberg, A Tornio, et al.
The Pharmacogenomics Journal|October 10, 2007
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolismC Rodríguez-Antona, M Niemi, J T Backman, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juiceZ Desta, K T Kivistö, J J Lilja, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|February 17, 2001
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrationsC Kyrklund, J T Backman, K T Kivistö, et al.
Pharmacology & Toxicology|December 23, 1999
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitroJ S Wang, J T Backman, X Wen, et al.
Clinical Pharmacology and Therapeutics|April 5, 2008
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivoA Tornio, M Niemi, M Neuvonen, et al.
Anaesthesia and Intensive Care|April 1, 2016
Intravenous lipid emulsion for levobupivacaine intoxication in acidotic and hypoxaemic pigsJ A Heinonen, M B Skrifvars, J Haasio, et al.
Pharmacology & Toxicology|November 24, 1999
Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazoleJ S Wang, X Wen, J T Backman, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylationJ T Backman, J Mäenpää, D J Belle, et al.
European Journal of Clinical Pharmacology|May 25, 2001
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazoleK T Kivistö, J S Wang, J T Backman, et al.
Clinical Pharmacology and Therapeutics|February 24, 2015
Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humansE K Tarkiainen, M T Holmberg, A Tornio, et al.
The Pharmacogenomics Journal|October 10, 2007
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolismC Rodríguez-Antona, M Niemi, J T Backman, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juiceZ Desta, K T Kivistö, J J Lilja, et al.
Pageof 7